1 study found for:    21856226 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
Condition: Myelogenous Leukemia, Chronic
Interventions: Drug: nilotinib;   Drug: imatinib

Indicates status has not been verified in more than two years